ACR 2007 News

 Drug Update: Rituximab
December 6, 2007
Repeat rituximab was notably effective in patients with DMARD-resistant RA, and the B-cell depleting agent is being tested in pediatric SLE and in Sjögren's syndrome...

Drug Update: Infliximab
December 5, 2007
Researchers offer advice on reducing infliximab infusion times in RA, predicting who will respond, and what to expect in patients with ankylosing spondylitis...

Drug Update: Abatacept
November 30, 2007
Researchers continue to argue for the cost-effectiveness of abatacept in treatment-resistant rheumatoid arthritis, but a real-world analysis raises questions about responses in routine clinical use. Safety data show no increased risk of malignancies or infection...

Update on Joint Replacement
November 28, 2007
Total joint replacement has reduced pain and disability in elderly patients with arthritis. The procedure is cost-effective even for high-risk patients, but it is associated with higher risk for cardiac complications if both joints are replaced during the same procedure, and it might be chosen by more African-American patients if finances were less of an issue...

Abatacept Wins Plaudits in Refractory JIA
November 26, 2007
The costimulation blocker abatacept may be a safe and effective option for juvenile idiopathic arthritis patients who have exhausted all other therapies...

Researchers "Shocked" at Enbrel's Efficacy in JRA
November 21, 2007
Etanercept (Enbrel®) is safe and effective in the long-term treatment of juvenile rheumatoid arthritis (JRA), according to new 8-year outcome data...

TNF-Blocker Plus MTX Slashes Heart Risk in RA
November 19, 2007
Combination therapy with a TNF-inhibitor plus MTX slashes heart attack risk by 80% in rheumatoid arthritis (RA) patients...

• ACR 2007 Video: Interviews
• ACR 2007 Video: Press Conferences